Rapid Genomics is Biotechnology in United States that focus on healthcare industry business. Founded in 2011. They cover business area such as developer, technology, agriculture, vaccine detection, evolutionary biology and healthcare industry, germplasm, stock, bioenergy, food, fiber, production, customer, genetic polymorphism, any organism, a reference genome sequence.
2011
( 13 years old in 2024 )
Healthcare Industry
-
747 South West 2nd Avenue
Suite 314
Gainesville, FL 32601
United States
Private
developertechnologyagriculturevaccine detectionevolutionary biology and healthcare industrygermplasmstockbioenergyfoodfiberproductioncustomergenetic polymorphismany organisma reference genome sequence
* We use standard office opening hours in near Rapid Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rapid Genomics is Biotechnology business from United States that founded in 2011 (13 years old in 2024), Rapid Genomics business is focusing on Healthcare Industry.
Rapid Genomics headquarter office and corporate office address is located in 747 South West 2nd Avenue Suite 314 Gainesville, FL 32601 United States.
Rapid Genomics was founded in United States.
In 2024, Rapid Genomics is currently focus on healthcare industry sector.
Above is snippet of Google Trends for "healthcare industry" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rapid Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.